• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Cardiology

Sex-related disparities in cardiovascular health care among patients with premature atherosclerotic cardiovascular disease

byBipandeep AbbatandAlex Chan
April 30, 2021
in Cardiology, Chronic Disease
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

RELATED REPORTS

2 Minute Medicine Rewind June 27, 2022

2 Minute Medicine Rewind June 13, 2022 

2 Minute Medicine Rewind June 6, 2022

1. In this cross-sectional study, women with premature atherosclerotic cardiovascular disease (ASCVD) and extremely premature ASCVD were less likely to receive antiplatelet agents or statins than men.

Evidence level rating: 2 (Good)

Secondary prevention guidelines highlight the importance of initiation antiplatelet and statin therapy in patients with ASCVD, especially in younger patients. In this nationwide cross-sectional study, data from patients enrolled in the Veterans with Premature Atherosclerosis (VITAL) registry was used to evaluate the disparities in secondary prevention in women with premature ASCVD (ASCVD event at 55 years or younger) and extremely premature ASCVD (ASCVD event at 40 years or younger). The primary outcomes evaluated were antiplatelet use, any statin therapy, high-intensity statin (HIS) therapy, and statin adherence. Statin adherence was assessed using a validated measurement of proportion of days covered (PDC), calculated by dividing the prescription’s covered days supply by total days in the given period. There were 147,600 patients (10,413 women and 137,187 men) with premature ASCVD (<55 years) involved in the study. In this group, adjusted regression analysis demonstrated that women were significantly less likely to receive antiplatelets (odds ratio [OR], 0.59; 95% CI, 0.56-0.61), any statin (OR, 0.66; 95% CI, 0.63-0.69) or HIS therapy (OR, 0.64; 95% CI, 0.60-0.67). Women were also less statin adherent than men (mean [SD], 0.67 [0.35] vs 0.72 [0.32]; coefficient, -0.01; 95% CI, -0.02 – -0.01). The study identified 9485 patients (1,340 women and 8,145 men) with extremely premature ASCVD (<55 years). In this group, an adjusted analysis showed that female sex was independently associated with lower odds of antiplatelet use (OR, 0.61; 95% CI, 0.53-0.70), any statin use (OR, 0.51; 95% CI, 0.44-0.58), and HIS use (OR, 0.45; 95% CI, 0.37-0.54). However, there were no significant sex-associated differences in statin adherence. Overall, this study revealed that women veterans with premature and extremely premature ASCVD receive less optimal secondary cardiovascular treatment compared to men.

Click to read the study in JAMA Cardiology

Image: PD

©2021 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: cardiologythrombosis
Previous Post

#VisualAbstract: Psilocybin does not significantly improve depressive scores compared to escitalopram

Next Post

ChAdOx1 nCov-19 AstraZeneca COVID-19 vaccine not effective against B.1.351 variant

RelatedReports

Implementation of pneumococcal vaccine programs linked to decreased antibiotic prescription
Chronic Disease

2 Minute Medicine Rewind June 27, 2022

June 27, 2022
Long-term outcomes for off-pump and on-pump CABG are similar
Weekly Rewinds

2 Minute Medicine Rewind June 13, 2022 

June 20, 2022
Weekly Rewinds

2 Minute Medicine Rewind June 6, 2022

June 6, 2022
Rivaroxaban likely reduces risk of recurrent stroke in specific subgroup of patients with embolic stroke of undetermined source
Cardiology

New-onset atrial fibrillation following hospitalization for pneumonia associated with increased thromboembolic risk

May 30, 2022
Next Post
Novel coronavirus identified from patients with pneumonia in Wuhan, China

ChAdOx1 nCov-19 AstraZeneca COVID-19 vaccine not effective against B.1.351 variant

Selexipag may decrease mortality related to pulmonary arterial hypertension: The GRIPHON study

Sotatercept decreased vascular resistance in pulmonary arterial hypertension

Novel biodegradable sirolimus-eluting stents non-inferior to durable everolimus-eluting stents [BIOSCIENCE trial]

Tailored antiplatelet therapy improves outcomes in patients undergoing percutaneous coronary intervention

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Stereotactic body radiotherapy as a state of the art treatment option in inoperable non-small cell lung cancer [Classics Series]
  • Health system-based care associated with better treatment use and high rates of tobacco abstinence at 3 months post-discharge in hospitalized smokers
  • APOEε4 genotype may increase risk of chronic traumatic encephalopathy following repetitive head impact
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.